The price of Viagra has risen again – despite expectations that it would droop to rival cheaper generic alternatives.
The erectile dysfunction drug is one of 100 best-selling Pfizer products to go up in price by as much as 20 percent, including common lung cancer and blood pressure treatments, according to the Financial Times.
The surprise move from the pharma giant comes just over a month after President Trump said he had persuaded ‘some of the big drug companies’ to ‘announce voluntary massive drops in prices’.
Read more of the original article from DailyMail
